Cargando…
Open peer commentary on “Prescribing anti‐amyloid immunotherapies to treat Alzheimer's disease: Fully informing patient decisions”
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661216/ https://www.ncbi.nlm.nih.gov/pubmed/38023619 http://dx.doi.org/10.1002/trc2.12437 |
| _version_ | 1785148458313711616 |
|---|---|
| author | Gandy, Sam |
| author_facet | Gandy, Sam |
| author_sort | Gandy, Sam |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10661216 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106612162023-11-20 Open peer commentary on “Prescribing anti‐amyloid immunotherapies to treat Alzheimer's disease: Fully informing patient decisions” Gandy, Sam Alzheimers Dement (N Y) Open Peer Commentary John Wiley and Sons Inc. 2023-11-20 /pmc/articles/PMC10661216/ /pubmed/38023619 http://dx.doi.org/10.1002/trc2.12437 Text en © 2023 The Authors. Alzheimer's & Dementia: Translational Research & Clinical Interventions published by Wiley Periodicals LLC on behalf of Alzheimer's Association. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Open Peer Commentary Gandy, Sam Open peer commentary on “Prescribing anti‐amyloid immunotherapies to treat Alzheimer's disease: Fully informing patient decisions” |
| title | Open peer commentary on “Prescribing anti‐amyloid immunotherapies to treat Alzheimer's disease: Fully informing patient decisions” |
| title_full | Open peer commentary on “Prescribing anti‐amyloid immunotherapies to treat Alzheimer's disease: Fully informing patient decisions” |
| title_fullStr | Open peer commentary on “Prescribing anti‐amyloid immunotherapies to treat Alzheimer's disease: Fully informing patient decisions” |
| title_full_unstemmed | Open peer commentary on “Prescribing anti‐amyloid immunotherapies to treat Alzheimer's disease: Fully informing patient decisions” |
| title_short | Open peer commentary on “Prescribing anti‐amyloid immunotherapies to treat Alzheimer's disease: Fully informing patient decisions” |
| title_sort | open peer commentary on “prescribing anti‐amyloid immunotherapies to treat alzheimer's disease: fully informing patient decisions” |
| topic | Open Peer Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661216/ https://www.ncbi.nlm.nih.gov/pubmed/38023619 http://dx.doi.org/10.1002/trc2.12437 |
| work_keys_str_mv | AT gandysam openpeercommentaryonprescribingantiamyloidimmunotherapiestotreatalzheimersdiseasefullyinformingpatientdecisions |